Invesco Ltd. Trevena Inc Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.2 - $0.5 $9,720 - $24,300	-48,600 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.41 - $0.63 $396 - $608	-966 Reduced 1.95%	48,600 $27,000
Q4 2021 Feb 14, 2022	SELL	$0.57 - $1.29 $2,395 - $5,421	-4,203 Reduced 7.82%	49,566 $29,000
Q3 2021 Nov 15, 2021	BUY	$1.11 - $1.7 $11,893 - $18,215	10,715 Added 24.89%	53,769 $66,000
Q2 2021 Aug 17, 2021	BUY	$1.46 - $2.25 $62,858 - $96,871	43,054 New	43,054 $73,000
Q1 2019 May 15, 2019	SELL	$0.51 - $1.88 $9,666 - $35,633	-18,954 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$0.39 - $3.47 $7,392 - $65,770	18,954 New	18,954 $8,000

Ticker TRVN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 173,680,992
Market Cap $691M
Description
Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.